F. Hoffmann-La Roche Ltd. (hereafter 'Roche') [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced its third quarter sales 2021 (January 1 - September 30, 2021).
Roche owns 59.89% of Chugai's outstanding shares (61.16% of the total number of shares issued excluding treasury stock) as of the end of September 2021.
Its investor updates and presentation materials can be found on its website (https://www.roche.com).
Chugai's performance for the period of January 1 to September 30, 2021 is included in the announced Roche Group's results.
Contact:
Media
Chugai Pharmaceutical Co., Ltd.
Media Relations Group
Corporate Communications Dept.
Tomoko Shimizu
Tel: +81-3-3273-0881
E-mail: pr@chugai-pharm.co.jp
Investors
Chugai Pharmaceutical Co., Ltd.
Investor Relations Group
Corporate Communications Dept.
Takayuki Sakurai
Tel: +81-3-3273-0554
E-mail: ir@chugai-pharm.co.jp
(C) 2021 Electronic News Publishing, source ENP Newswire